Extracellular vesicles (EVs) are lipid bilayered membrane structures released by all cells. Most EV studies have been performed by using cell lines or body fluids, but the number of studies on tissue-derived EVs is still limited. Here, we present a protocol to isolate up to six different EV subpopulations directly from tissues. The approach includes enzymatic treatment of dissociated tissues followed by differential ultracentrifugation and density separation. The isolated EV subpopulations are characterized by electron microscopy and RNA profiling. In addition, their protein cargo can be determined with mass spectrometry, western blot and ExoView. Tissue-EV isolation can be performed in 22 h, but a simplified version can be completed in 8 h. Most experiments with the protocol have used human melanoma metastases, but the protocol can be applied to other cancer and non-cancer tissues. The procedure can be adopted by researchers experienced with cell culture and EV isolation.
This is a preview of subscription content, access via your institution
Open Access articles citing this article.
miR-31-5p from placental and peripheral blood exosomes is a potential biomarker to diagnose preeclampsia
Hereditas Open Access 19 September 2022
Mesenchymal stem cell-derived exosomes in cancer therapy resistance: recent advances and therapeutic potential
Molecular Cancer Open Access 13 September 2022
HRS phosphorylation drives immunosuppressive exosome secretion and restricts CD8+ T-cell infiltration into tumors
Nature Communications Open Access 14 July 2022
Subscribe to Nature+
Get immediate online access to the entire Nature family of 50+ journals
Subscribe to Journal
Get full journal access for 1 year
only $8.25 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Get time limited or full article access on ReadCube.
All prices are NET prices.
All identified proteins and their expression are provided in the supporting primary research article by Crescitelli et al35. The full-length, unprocessed blots and gels related to Extended Data Fig. 5 have been submitted to the figshare repository (https://figshare.com/articles/figure/Isolation_and_characterization_of_extracellular_vesicles_from_tissues_WesternBlot_Extended_data_Fig_4_pdf/12854744). All the information regarding flow cytometry experiments is available as supplementary information (Supplementary Tables 1 and 2) to this article. All parameters have been submitted to EVtrack (http://evtrack.org/) in the original publication35 (http://evtrack.org/search_results.php?evtraqid=EV190108&pmid=&author=&compl_score=&biofluid=&study_aim=&isolation_method=&species=&prot_methods=&keyword=&part_methods=&year=&submit=1).
The MS proteomics data have been deposited to the ProteomeXchange Consortium via the PRIDE90 partner repository with the dataset identifier PXD021694.
Valadi, H. et al. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat. Cell Biol. 9, 654–659 (2007).
Xiao, H. et al. Mast cell exosomes promote lung adenocarcinoma cell proliferation—role of KIT-stem cell factor signaling. Cell Commun. Signal. 12, 64 (2014).
Colombo, M., Raposo, G. & Théry, C. Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles. Annu. Rev. Cell Dev. Biol. 30, 255–289 (2014).
Kim, C. W. et al. Extracellular membrane vesicles from tumor cells promote angiogenesis via sphingomyelin. Cancer Res. 62, 6312–6317 (2002).
Al-Nedawi, K. & Read, J. Analysis of extracellular vesicles in the tumor microenvironment. Methods Mol. Biol. 1458, 195–202 (2016).
Ji, Q. et al. Primary tumors release ITGBL1-rich extracellular vesicles to promote distal metastatic tumor growth through fibroblast-niche formation. Nat. Commun. 11, 1211 (2020).
Nishida-Aoki, N. et al. Disruption of circulating extracellular vesicles as a novel therapeutic strategy against cancer metastasis. Mol. Ther. 25, 181–191 (2017).
Gangadaran, P., Hong, C. M. & Ahn, B. C. An update on in vivo imaging of extracellular vesicles as drug delivery vehicles. Front. Pharmacol. 9, 169 (2018).
Luga, V. et al. Exosomes mediate stromal mobilization of autocrine Wnt-PCP signaling in breast cancer cell migration. Cell 151, 1542–1556 (2012).
Atay, S. et al. Oncogenic KIT-containing exosomes increase gastrointestinal stromal tumor cell invasion. Proc. Natl Acad. Sci. U. S. A. 111, 711–716 (2014).
Qu, J. L. et al. Gastric cancer exosomes promote tumour cell proliferation through PI3K/Akt and MAPK/ERK activation. Dig. Liver Dis. 41, 875–880 (2009).
Urabe, F. et al. Extracellular vesicles as biomarkers and therapeutic targets for cancer. Am. J. Physiol. Cell Physiol. 318, C29–C39 (2020).
Raposo, G. & Stoorvogel, W. Extracellular vesicles: exosomes, microvesicles, and friends. J. Cell Biol. 200, 373–383 (2013).
Crescitelli, R. et al. Distinct RNA profiles in subpopulations of extracellular vesicles: apoptotic bodies, microvesicles and exosomes. J. Extracell. Vesicles 2, 1 (2013).
Kowal, J. et al. Proteomic comparison defines novel markers to characterize heterogeneous populations of extracellular vesicle subtypes. Proc. Natl Acad. Sci. U. S. A. 113, E968–E977 (2016).
Lässer, C. et al. Two distinct extracellular RNA signatures released by a single cell type identified by microarray and next-generation sequencing. RNA Biol. 14, 58–72 (2017).
Zabeo, D. et al. Exosomes purified from a single cell type have diverse morphology. J. Extracell. Vesicles 6, 1329476 (2017).
Willms, E. et al. Cells release subpopulations of exosomes with distinct molecular and biological properties. Sci. Rep. 6, 22519 (2016).
Lässer, C. et al. Human saliva, plasma and breast milk exosomes contain RNA: uptake by macrophages. J. Transl. Med. 9, 9 (2011).
Keller, S., Ridinger, J., Rupp, A. K., Janssen, J. W. & Altevogt, P. Body fluid derived exosomes as a novel template for clinical diagnostics. J. Transl. Med. 9, 86 (2011).
Höög, J. L. & Lötvall, J. Diversity of extracellular vesicles in human ejaculates revealed by cryo-electron microscopy. J. Extracell. Vesicles 4, 28680 (2015).
Domcke, S., Sinha, R., Levine, D. A., Sander, C. & Schultz, N. Evaluating cell lines as tumour models by comparison of genomic profiles. Nat. Commun. 4, 2126 (2013).
Chen, B., Sirota, M., Fan-Minogue, H., Hadley, D. & Butte, A. J. Relating hepatocellular carcinoma tumor samples and cell lines using gene expression data in translational research. BMC Med. Genomics 8,, S5 (2015).
Allen, M., Bjerke, M., Edlund, H., Nelander, S. & Westermark, B. Origin of the U87MG glioma cell line: good news and bad news. Sci. Transl. Med. 8, 354re353 (2016).
Perez-Gonzalez, R., Gauthier, S. A., Kumar, A. & Levy, E. The exosome secretory pathway transports amyloid precursor protein carboxyl-terminal fragments from the cell into the brain extracellular space. J. Biol. Chem. 287, 43108–43115 (2012).
Gallart-Palau, X., Serra, A. & Sze, S. K. Enrichment of extracellular vesicles from tissues of the central nervous system by PROSPR. Mol. Neurodegener. 11, 41 (2016).
Vella, L. et al. A rigorous method to enrich for exosomes from brain tissue. J. Extracell. Vesicles 6, 1348885 (2017).
Hurwitz, S. N. et al. An optimized method for enrichment of whole brain-derived extracellular vesicles reveals insight into neurodegenerative processes in a mouse model of Alzheimer’s disease. J. Neurosci. Methods 307, 210–220 (2018).
Hurwitz, S. N., Olcese, J. M. & Meckes, D. G., Jr. Extraction of extracellular vesicles from whole tissue. J. Vis. Exp. (144), e59143 (2019).
Huang, Y. et al. Influence of species and processing parameters on recovery and content of brain tissue-derived extracellular vesicles. J. Extracell. Vesicles 9, 1 (2020).
Yelamanchili, S. V. et al. MiR-21 in extracellular vesicles leads to neurotoxicity via TLR7 signaling in SIV neurological disease. PloS Pathog. 11, e1005032 (2015).
Banigan, M. G. et al. Differential expression of exosomal microRNAs in prefrontal cortices of schizophrenia and bipolar disorder patients. PLoS One 8, e48814 (2013).
Polanco, J. C., Scicluna, B. J., Hill, A. F. & Götz, J. Extracellular vesicles isolated from the brains of rTg4510 mice seed tau protein aggregation in a threshold-dependent manner. J. Biol. Chem. 291, 12445–12466 (2016).
Jang, S. C. et al. Mitochondrial protein enriched extracellular vesicles discovered in human melanoma tissues can be detected in patient plasma. J. Extracell. Vesicles 8, 1635420 (2019).
Crescitelli, R. et al. Subpopulations of extracellular vesicles from human metastatic melanoma tissue identified by quantitative proteomics after optimized isolation. J. Extracell. Vesicles 9, 1722433 (2020).
Lunt, S. J., Chaudary, N. & Hill, R. P. The tumor microenvironment and metastatic disease. Clin. Exp. Metastasis 26, 19–34 (2009).
Su, M.-J., Parayath, N. N. & Amiji, M. M. Exosome-mediated communication in the tumor microenvironment. In Diagnostic and Therapeutic Applications of Exosomes in Cancer (eds. Amiji, M. & Ramesh, R.) 187–218 (Academic Press, London, UK, 2018).
Skalnikova, H. K. et al. Isolation and characterization of small extracellular vesicles from porcine blood plasma, cerebrospinal fluid, and seminal plasma. Proteomes 7, 17 (2019).
Carnino, J. M., Lee, H. & Jin, Y. Isolation and characterization of extracellular vesicles from Broncho-alveolar lavage fluid: a review and comparison of different methods. Respir. Res. 20, 240 (2019).
Monguió-Tortajada, M. et al. Extracellular-vesicle isolation from different biological fluids by size-exclusion chromatography. Curr. Protoc. Stem Cell Biol. 49, e82 (2019).
Momen-Heravi, F. et al. Current methods for the isolation of extracellular vesicles. Biol. Chem. 394, 1253–1262 (2013).
Balaj, L. et al. Tumour microvesicles contain retrotransposon elements and amplified oncogene sequences. Nat. Commun. 2, 180 (2011).
Steenbeek, S. C. et al. Cancer cells copy migratory behavior and exchange signaling networks via extracellular vesicles. Embo J. 37,, e98357 (2018).
Cianciaruso, C. et al. Molecular profiling and functional analysis of macrophage-derived tumor extracellular vesicles. Cell Rep. 27, 3062–3080.e11 (2019).
Jeppesen, D. K. et al. Reassessment of exosome composition. Cell 177, 428–445.e18 (2019).
Yousef, H., Czupalla, C. J., Lee, D., Butcher, E. C. & Wyss-Coray, T. Papain-based single cell isolation of primary murine brain endothelial cells using flow cytometry. Bio Protoc. 8, e3091 (2018).
Angyal, A. et al. CD16/32-specific biotinylated 2.4G2 single-chain Fv complexed with avidin-FITC enhances FITC-specific humoral immune response in vivo in a CD16-dependent manner. Int. Immunol. 22, 71–80 (2010).
Fan, Y. et al. Low intraprostatic DHT promotes the infiltration of CD8+ T cells in BPH tissues via modulation of CCL5 secretion. Mediators Inflamm. 2014, 397815 (2014).
Benck, C. J., Martinov, T., Fife, B. T. & Chatterjea, D. Isolation of infiltrating leukocytes from mouse skin using enzymatic digest and gradient separation. J. Vis. Exp. (107), e53638 (2016).
Uchea, C., Owen, S. F. & Chipman, J. K. Functional xenobiotic metabolism and efflux transporters in trout hepatocyte spheroid cultures. Toxicol. Res. (Camb.) 4, 494–507 (2015).
Autengruber, A., Gereke, M., Hansen, G., Hennig, C. & Bruder, D. Impact of enzymatic tissue disintegration on the level of surface molecule expression and immune cell function. Eur. J. Microbiol. Immunol. (Bp 2, 112–120 (2012).
Möller, K., Stahl, T., Boltze, J. & Wagner, D. C. Isolation of inflammatory cells from rat brain tissue after stroke. Exp. Transl. Stroke Med. 4, 20 (2012).
Takeuchi, Y., Higuchi, K., Yatabe, T., Miwa, M. & Yoshizaki, G. Development of spermatogonial cell transplantation in Nibe croaker, Nibea mitsukurii (Perciformes, Sciaenidae). Biol. Reprod. 81, 1055–1063 (2009).
Legroux, L. et al. An optimized method to process mouse CNS to simultaneously analyze neural cells and leukocytes by flow cytometry. J. Neurosci. Methods 247, 23–31 (2015).
Berdnikovs, S., Abdala-Valencia, H. & Cook-Mills, J. M. Endothelial cell PTP1B regulates leukocyte recruitment during allergic inflammation. Am. J. Physiol. Lung Cell. Mol. Physiol. 304, L240–L249 (2013).
Filtjens, J. et al. Expression of the inhibitory Ly49E receptor is not critically involved in the immune response against cutaneous, pulmonary or liver tumours. Sci. Rep. 6, 30564 (2016).
Welte, Y., Davies, C., Schäfer, R. & Regenbrecht, C. R. Patient derived cell culture and isolation of CD133+ putative cancer stem cells from melanoma. J. Vis. Exp. (73), e50200 (2013).
Dunleavey, J. M. et al. Vascular channels formed by subpopulations of PECAM1+ melanoma cells. Nat. Commun. 5, 5200 (2014).
Quintana, E. et al. Phenotypic heterogeneity among tumorigenic melanoma cells from patients that is reversible and not hierarchically organized. Cancer Cell 18, 510–523 (2010).
Zhou, J. et al. Colorectal cancer cell surface protein profiling using an antibody microarray and fluorescence multiplexing. J. Vis. Exp. (55), 3322 (2011).
Weigmann, B. et al. Isolation and subsequent analysis of murine lamina propria mononuclear cells from colonic tissue. Nat. Protoc. 2, 2307–2311 (2007).
Lunavat, T. R. et al. BRAFV600 inhibition alters the microRNA cargo in the vesicular secretome of malignant melanoma cells. Proc. Natl Acad. Sci. U. S. A. 114, E5930–E5939 (2017).
Jeurissen, S. et al. The isolation of morphologically intact and biologically active extracellular vesicles from the secretome of cancer-associated adipose tissue. Cell Adh. Mig.r 11, 196–204 (2017).
Jingushi, K. et al. Extracellular vesicles isolated from human renal cell carcinoma tissues disrupt vascular endothelial cell morphology via azurocidin. Int. J. Cancer 142, 607–617 (2018).
Van Deun, J. et al. The impact of disparate isolation methods for extracellular vesicles on downstream RNA profiling. J. Extracell. Vesicles 3, 1 (2014).
Chen, C., Lin, B. R., Hsu, M. Y. & Cheng, C. M. Paper-based devices for isolation and characterization of extracellular vesicles. J. Vis. Exp. (98), e52722 (2015).
Théry, C., Amigorena, S., Raposo, G. & Clayton, A. Isolation and characterization of exosomes from cell culture supernatants and biological fluids. Curr. Protoc. Cell Biol. Chapter 3, Unit 3.22 (2006).
Konoshenko, M. Y., Lekchnov, E. A., Vlassov, A. V. & Laktionov, P. P. Isolation of extracellular vesicles: general methodologies and latest trends. Biomed. Res. Int. 2018, 8545347 (2018).
Jang, S. C. et al. Bioinspired exosome-mimetic nanovesicles for targeted delivery of chemotherapeutics to malignant tumors. ACS Nano 7, 7698–7710 (2013).
Hyatt, G. W. & Wilber, M. C. The storage of human tissues for surgical use. Postgrad. Med. J. 35, 338–343 (1959).
World MedicalAssociation. World medical association declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA 310, 2191–2194 (2013).
Haukaas, T. H. et al. Impact of freezing delay time on tissue samples for metabolomic studies. Front. Oncol. 6, 17 (2016).
Bæk, R., Søndergaard, E. K. L., Varming, K. & Jørgensen, M. M. The impact of various preanalytical treatments on the phenotype of small extracellular vesicles in blood analyzed by protein microarray. J. Immunol. Methods 438, 11–20 (2016).
Yuana, Y. et al. Handling and storage of human body fluids for analysis of extracellular vesicles. J. Extracell. Vesicles 4, 29260 (2015).
Virues Delgadillo, J., Delorme, S., El-Ayoubi, R., DiRaddo, R. & Hatzikiriakos, S. Effect of freezing on the passive mechanical properties of arterial samples. J. Biomed. Sci. Eng. 3, 645–652 (2010).
Han, B. & Bischof, J. C. Engineering challenges in tissue preservation. Cell Preserv. Technol. 2, 91–112 (2004).
Nayar, S., Campos, J., Steinthal, N. & Barone, F. Tissue digestion for stromal cell and leukocyte isolation. Methods Mol. Biol. 1591, 225–234 (2017).
Kusuma, G. D. et al. To Protect and to Preserve: Novel Preservation Strategies for Extracellular Vesicles. Front Pharmacol 9, 1199 (2018).
Jayachandran, M., Miller, V. M., Heit, J. A. & Owen, W. G. Methodology for isolation, identification and characterization of microvesicles in peripheral blood. J. Immunol. Methods 375, 207–214 (2012).
Szatanek, R., Baran, J., Siedlar, M. & Baj-Krzyworzeka, M. Isolation of extracellular vesicles: determining the correct approach (review). Int. J. Mol. Med. 36, 11–17 (2015).
Théry, C. et al. Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. J. Extracell. Vesicles 7, 1535750 (2018).
Lunavat, T. R. et al. Small RNA deep sequencing discriminates subsets of extracellular vesicles released by melanoma cells—evidence of unique microRNA cargos. RNA Biol. 12, 810–823 (2015).
Cvjetkovic, A. et al. Detailed analysis of protein topology of extracellular vesicles—evidence of unconventional membrane protein orientation. Sci. Rep. 6, 36338 (2016).
Tian, Y. et al. Quality and efficiency assessment of six extracellular vesicle isolation methods by nano-flow cytometry. J. Extracell. Vesicles 9, 1697028 (2020).
Wiśniewski, J. R., Zougman, A., Nagaraj, N. & Mann, M. Universal sample preparation method for proteome analysis. Nat. Methods 6, 359–362 (2009).
McAlister, G. C. et al. MultiNotch MS3 enables accurate, sensitive, and multiplexed detection of differential expression across cancer cell line proteomes. Anal. Chem. 86, 7150–7158 (2014).
Kim, D.-K. et al. EVpedia: an integrated database of high-throughput data for systemic analyses of extracellular vesicles. J. Extracell. Vesicles 2, 1 (2013).
Keerthikumar, S. et al. ExoCarta: a web-based compendium of exosomal cargo. J. Mol. Biol. 428, 688–692 (2016).
Kalra, H. et al. Vesiclepedia: a compendium for extracellular vesicles with continuous community annotation. PLoS Biol. 10, e1001450 (2012).
Deutsch, E. W. et al. The ProteomeXchange consortium in 2017: supporting the cultural change in proteomics public data deposition. Nucleic Acids Res. 45, D1100–D1106 (2016).
We thank the Centre for Cellular Imaging at the University of Gothenburg and the National Microscopy Infrastructure (VR-RFI 2016-00968)) for microscopy support and, in particular, M. Micaroni for his assistance in buffer preparation for sample preparation and image acquisition. We thank the Proteomic Core Facility at the University of Gothenburg for performing the LC-tandem MS analysis, in particular, A. Thorsell, J. Fuchs and B.-M. Olsson. The Proteomics Core Facility is grateful to the Inga-Britt and Arne Lundbergs Forskningsstiftlese for the donation of the Orbitrap Fusion Tribrid MS instrument. We thank R. Cattaneo for his assistance with figure preparation. We thank the VBG Group Herman Krefting Foundation for Asthma and Allergy Research for supporting the Krefting Research Centre at the University of Gothenburg. This work was funded by the Swedish Research Council (K2014-85X-22504-01-3), the Swedish Heart and Lung Foundation (20120528), the Swedish Cancer Foundation (CAN2014/844) and the Knut and Alice Wallenberg Foundation (Wallenberg Centre for Molecular and Translational Medicine, University of Gothenburg, Sweden).
The authors have developed multiple EV-associated patents for putative clinical utilization: US20200088734A1, United States, R.C., J.L.; WO2020146390A1, WIPO (PCT), R.C., J.L.; GB2574785A, United Kingdom, C.L., J.L.; US20070298118A1, United States, J.L.; CA3017586A1, Canada, J.L.; US20200163998A1, United States, J.L.; and WO2014076137A1, WIPO (PCT), J.L. J.L. owns equity in Codiak BioSciences Inc. and Exocure Biosciences Inc. and consults in the field of EVs through Vesiclebio AB. R.C. and C.L. own equity in Exocure Bioscience Inc.
Peer review information Nature Protocols thanks Rienk Nieuwland and the other, anonymous, reviewer(s) for their contribution to the peer review of this work.
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Key references using this protocol
Crescitelli, R. et al. J. Extracell. Vesicles 9, 1722433 (2020): https://doi.org/10.1080/20013078.2020.1722433
Jang, S. C. et al. J. Extracell. Vesicles 8, 1635420 (2019): https://doi.org/10.1080/20013078.2019.1635420
Extended Data Fig. 1 Representative sections of mouse and human tissue and EVs isolated from these tissues.
a and b, Sections of mouse tissues from subcutaneous melanoma tissue (a) and colon cancer (b) are shown. EVs isolated from subcutaneous melanoma and colon cancer tissue shown in a1–3 and b1–3 are as follows: lEVs (1), sEVs (2) and a mixture of both lEVs and sEVs isolated by using the iodixanol cushion separation (3). c and d, Sections of tissues isolated from human colon mucosa (c) and colon cancer (d) are shown. EVs in the extracellular space are indicated with red arrows. Mixtures of both lEVs and sEVs isolated by using iodixanol cushion separation from colon mucosa and tumor tissue are shown in c1 and d1 (scale bars: a = 1 µm, a1–a3 = 500 nm, b = 1 µm, b1–b3 = 200 nm, c = 2 µm, the higher-magnification panel in c = 500 nm, c1 = 200 nm, d = 1 µm, the higher-magnification panel in d = 500 nm, d1 = 200 nm). Human samples were collected and processed in alignment with the Regional Ethical Review Board at the University of Gothenburg, Sweden (melanoma metastases #096-12 and #995-16; colon cancer and colon mucosa #118-15) and according to institutional animal use and care guidelines (Directive 2010/63/EU on the protection of animals used for scientific purposes).
Extended Data Fig. 2 Protocol optimization: enzymatic treatment applied at different steps of the procedure.
a, The 2018 Protocol was used to isolate EVs without using collagenase D and DNase I (blue arrows). In the 2019 Protocol, collagenase and DNase I treatment was applied to the re-suspended vesicle-enriched pellets (green arrows). In the Final Protocol, collagenase D and DNase I treatment were applied directly to the tissue pieces after the dissociating step (red arrows). b and c, Micrograms of proteins isolated from lEVs (b) and sEVs (c) normalized to the grams of tissue for each protocol; 2018 Protocol, n = 4; 2019 Protocol, n = 2; Final Protocol 3, n = 13. Human samples were collected and processed in alignment with the Regional Ethical Review Board at the University of Gothenburg, Sweden (#096-12 and #995-16). The patient provided informed written consent. The image is modified from Crescitelli et al.35.
Extended Data Fig. 3 Evaluation of the molecular effects of collagenase D and DNase I on CD9, CD63 and CD81.
a and b, Flow cytometry analysis showing the gating and the expression of CD9, CD63 and CD81 after collagenase D and DNase I treatment of HMC-1 cells (a) and lEVs and sEVs (b). The EVs were bound to anti-CD63 beads before analysis. The viability of HMC-1 cells after enzymatic treatment was evaluated with flow cytometry and 7-AAD. The information about the antibodies, cell line, EV-binding beads, instruments and software used to perform flow cytometry experiments is listed in Supplementary Table 1. The information about the cell and EV populations analyzed in the flow cytometry experiments is given in Supplementary Table 2. c, The expression of CD9, CD63 and CD81 on EVs after collagenase D and DNase I treatment was investigated by ExoView. Enzymatic treatment was performed on HMC1 cells and their conditional media (containing EVs), and the media were loaded onto the chips. The results are presented as the mean, but individual values from three different experiments are shown as well. n = 3. FSC-A, forward scatter area; K, thousand; PE, phycoerithrin; SSC-A, side scatter area. The image is modified from Crescitelli et al.35.
Extended Data Fig. 4 Quantitative proteomic analysis (tandem mass tag (TMT)) of the EV subpopulations isolated from cutaneous melanoma metastatic tissues.
Lists of the top 100 proteins identified from three online EV databases (EVpedia, ExoCarta and VesiclePedia87,88,89) were used to construct a list of common EV proteins. Furthermore, new markers suggested by Kowal and colleagues15 and the protein AGO2 were added to the list. After the duplicates were removed, a multi-group comparison was performed in Qlucore. Proteins differentially expressed in our dataset (P = 0.01, Q = 0.02) are shown in the heat map. Human samples were collected and processed in alignment with the Regional Ethical Review Board at the University of Gothenburg, Sweden (#096-12 and #995-16). The patient provided informed written consent. The image is modified from Crescitelli et al.35.
a, Western blot was used to investigate the presence of vesicle markers in lEVs and sEVs, including CD63, flotillin-1, CD9 and CD81, as well as the endoplasmatic reticulum protein calnexin. 10 μg of proteins was loaded per sample. b, Western blot was performed to validate a selection of proteins from the TMT analysis in all six EV subpopulations from two cutaneous melanoma metastatic tissues, including ADAM10, mitofillin, flotillin-1 and CD81. 4 μg of total protein was loaded per sample except for the western blot of large HD EVs from tumor 1 and 2 and the western blot of small HD EVs from tumor 2. The EV yield was insufficient; thus, 36 µl (maximum volume) of EVs was loaded instead, and they corresponded to 0.6, 0.7 and 2.5 µg of proteins. Human samples were collected and processed in alignment with the Regional Ethical Review Board at the University of Gothenburg, Sweden (#096-12 and #995-16). The patient provided informed written consent. The image is modified from Crescitelli et al.35.
About this article
Cite this article
Crescitelli, R., Lässer, C. & Lötvall, J. Isolation and characterization of extracellular vesicle subpopulations from tissues. Nat Protoc 16, 1548–1580 (2021). https://doi.org/10.1038/s41596-020-00466-1
Mesenchymal stem cell-derived exosomes in cancer therapy resistance: recent advances and therapeutic potential
Molecular Cancer (2022)
miR-31-5p from placental and peripheral blood exosomes is a potential biomarker to diagnose preeclampsia
Communications Biology (2022)
Scientific Reports (2022)
Isolation of mitochondria-derived mitovesicles and subpopulations of microvesicles and exosomes from brain tissues
Nature Protocols (2022)